Program Book - Confex

ACR/ARHP Poster Session B
1266. Evaluation of A Novel Homogeneous Mobility Shift Assay
for the Measurement of Human Antibodies-to-Infliximab
and Infliximab Levels in Patient Serum. Shui Long Wang,
Linda Ohrmund, Scott Hauenstein, Jared Salbato, Rukmini
Reddy, Patrick Monk, Steven Lockton, Nicholas Ling and
Sharat Singh, Prometheus Laboratories, San Diego, CA
1267. Tofacitinib Reduces Interferon-γ and Interleukin-17
Production From CD4+ T Cells in Patients with Rheumatoid
Arthritis. Satoshi Kubo, Kunihiro Yamaoka, Koshiro
Sonomoto, Keisuke Maeshima, Shintaro Hirata, Kazuhisa
Nakano, Norifumi Sawamukai, Masao Nawata, Shigeru
Iwata, Kazuyoshi Saito and Yoshiya Tanaka, University of
Occupational and Environmental Health, Japan, Kitakyushu,
Japan
1268. A Phase 1, Randomized, Double-Blind, Placebo-
Controlled, Multiple, Intravenous, Ascending-Dose Study
of Sirukumab in Patients with Cutaneous or Systemic
Lupus Erythematosus. Jacek C. Szepietowski 1 , Surasak
Nilganuwong 2 , Anna Wozniacka 3 , Annegret Kuhn 4 , Filippa
Nyberg 5 , Jacek Szechinski 1 , Ronald F. van Vollenhoven 6 ,
Anders Bengtsson 7 , Adam Reich 1 , Dick de Vries 8 , Bart van
Hartingsveldt 8 , Bei Zhou 9 and Benjamin Hsu 10 , 1 Wroclaw
Medical University, Wroclaw, Poland, 2 Siriraj Hospital,
Bangkok, Thailand, 3 Medical University of Lodz, Lodz,
Poland, 4 University of Münster, Münster, Germany,
5
Karolinska Institutet, Danderyd Hospital, Stockholm,
Sweden, 6 Karolinska Institute, Stockholm, Sweden,
7
Department of Rheumatology, Lund University Hospital,
Sweden, 8 Janssen Biologics B.V., Leiden, Netherlands,
9
Centocor Research & Development, a Division of Johnson
& Johnson Pharmaceutical Research & Development,
LLC, Malvern, PA, 10 Centocor R&D, a division of J&J
Pharmaceutical R& D, LLC/Univ. of Pennsylvania, Malvern/
Philadelphia, PA
1269. Meta-Analysis Suggests Intensive Non-Biologic
Combination Therapy with Step-Down Prednisolone
May Also ‘Disconnect’ Disease Activity and Damage in
Rheumatoid Arthritis. Maarten Boers 1 , Lilian H.D. van Tuyl 1 ,
Marianne van den Broek 2 , Piet J. Kostense 1 and Cornelia
F. Allaart 2 , 1 VU University Medical Center, Amsterdam,
Netherlands, 2 Leiden University Medical Center, Leiden,
Netherlands
1270. Clinical Response and B Cell Analysis by High-Sensitive
Flowcytometry After the Second Course of Rituximab.
Hans-Peter Brezinschek 1 , Franz Rainer 2 , Kerstin Brickmann 1 ,
Raimund Lunzer 2 and Winfried B. Graninger 1 , 1 Medical
University Graz, Graz, Austria, 2 Hospital Barmherzige
Brueder, Graz- Eggenberg, Austria
1271. Comparison of Tocilizumab and TNF Inhibitor Therapy in
Rheumatoid Arthritis. Jörg Kaufmann 1 , Susanne Seel 2 and
Anne-Eve Roske 3 , 1 Rheumatologist, Ludwigsfelde, Germany,
2
Ambulant Centres f. Rheumatology, Ludwigsfelde, Germany,
3
Roche Pharma AG, Grenzach-Wyhlen, Germany
1272. Efficacy Evaluation of Tocilizumab with the New ACR/
EULAR Remission Criteria and DAS28-ESR. Tomonori Ishii 1 ,
Yasuhiko Hirabayashi 2 and Michinoku Tocilizumab Study
Group 3 , 1 Department of Hematology and Rheumatology,
Tohoku University Graduate School of Medicine, Sendai,
Japan, 2 Hikarigaoka Spellman Hospital, Sendai, Japan,
3
Senndai
1273. High Levels of Serum IL-6 but Not CRP or TNF-α During
Tocilizumab Treatment Induces Myalgia Among the
Patients with Rheumatoid Arthritis. Osamu Saiki 1 and
Hiroshi Uda 2 , 1 Shiraishi Hospital, Imabari, Japan, 2 Keiseikai
Hospital, Higashiosaka, Japan
1274. Development of a Novel Recombinant Biotherapeutic
with Applications in Targeted Therapy of Human Arthritis.
Panagiotis Kamperidis 1 , Tahereh Kamalati 1 , Mathieu
Ferrari 1 , Lewis Lee 1 , Rita Jones 1 , Toby Garrood 1 , Malcolm
D. Smith 2 , Soraya Diez-Posada 1 , Chris Hughes 1 , Ciara
Finucane 1 , Stephen Mather 1 , Ahuva Nissim 1 , Andrew J. T.
George 1 and Costantino Pitzalis 3 , 1 London, United Kingdom,
2
Adelaide, Australia, 3 Centre for Experimental Medicine and
Rheumatology, QMUL, London, United Kingdom
1275. Gene Expression Profiling of Folate Pathway Related
Genes in Methotrexate naïve- and Methotrexate-Treated
Rheumatoid Arthritis Patients. Marjolein Blits 1 , Gerrit
Jansen 1 , Yehuda G. Assaraf 2 and Cornelis L. Verweij 1 , 1 VU
University Medical Center, Amsterdam, Netherlands,
2
Technion, Haifa, Israel
1276. Retrospective Analysis of the Efficacy of Tacrolimus in
Rheumatoid Arthritis: Suggestive Synergistic Effects with
Methotrexate. Kenta Hoshi, Sumiaki Tanaka, Tatsuhiko
Wada, Junichi Tanaka, Tatsuo Nagai and Shunsei Hirohata,
Kitasato University School of Medicine, Sagamihara, Japan
1277. Anti-CCP Titers Are Predictive of the Response to
Biological Agents in Patients with Rheumatoid Arthritis.
Ryo Takahashi 1 , Ryo Yanai 1 , Hidekazu Furuya 1 , Kuninobu
Wakabayashi 1 , Tsuyoshi Odai 1 , Takeo Isozaki 2 , Nobuyuki
Yajima 1 , Yusuke Miwa 3 and Tsuyoshi Kasama 1 , 1 Showa
University School of Med, Shinagawa-ku Tokyo, Japan,
2
University of Michigan Medical School, Ann Arbor, MI,
3
Division of Rheumatology, Tokto, Japan
1278. Abatacept Reduces N-Terminal Pro Brain Natriuretic
Peptide Levels in Patients with Rheumatoid Arthritis:
Results From a Prospective Cohort Study. Inge A.M. van
den Oever 1 and Michael T. Nurmohamed 2 , 1 Jan van Breemen
Research Institute Reade, Amsterdam, Netherlands, 2 Reade,
Centre for Rehabilitation and Rheumatology, Amsterdam,
Netherlands
1279. Do Impared Memory, Cognitive Dysfonction and Distress
Play a Role In Methotrexate-Related Pancytopenia In
Rheumatoid Arthritis Patients Salim Donmez 1 , Yavuz
Pehlivan 2 , Omer Nuri Pamuk 1 , Bunyamin Kisacik 2 , Gulsum
Emel Pamuk 1 , Ahmet Mesut Onat 2 , Mehmet Sayarlioglu 3 and
Gözde Yildirim Çetin 3 , 1 Edirne, Turkey, 2 Gaziantep, Turkey,
3
Kahramanmaras, Turkey
226
2011 Program Book